GRK2 and autoimmune disease: Overall, further detailing GRK2 and β-arrestin mechanism of action are warranted to better understand this signaling pathway and to evaluate the pharmacological potential of targeting these proteins in the treatment of acute inflammatory responses, autoimmune diseases, and pain.